Having trouble viewing email? View in web browser
Hologic
Hologic

MammoSite 5-day targeted radiation therapy allows your patients to be treated for breast cancer in 5 days vs. 5-7 weeks, while sparing healthy tissue and organs the effects of radiation.

Built on 6-year clinical data and with over 65,000 patients treated, MammoSite is the leader in targeted radiation therapy for breast cancer.*

Our commitment to women

As a leader in women’s health it is our mission and obligation to do the best we can for women’s healthcare.

Learn more at MammoSite.com
A website devoted to thousands of women who have confronted the challenges of breast cancer.
A global women’s health initiative brought to you by Hologic.


To learn more visit Hologic at ACRO 2013, Booth #21.

 
*Factors Associated with Optimal Long-Term Cosmetic Results in Patients Treated with Accelerated Partial Breast Irradiation Using Balloon-Based Brachytherapy. F. A. Vicini, M. Keisch, C. Shah, S. Goyal, A. J. Khan, P. D. Beitsch, M. Lyden, B. G. Haffty Int Jour of Rad Oncol Biol Physics, 2011, 07.011.

Hologic, MammoSite and associated logos are trademarks and/or registered trademarks of Hologic and/or its subsidiaries in the U.S. and/or other countries. This information is intended for medical professionals in the U.S. and other markets, and is not intended as a product solicitation or promotion where such activities are prohibited. Because Hologic materials are distributed through websites, eBroadcasts and tradeshows, it is not always possible to control where such materials appear. For specific information on what products are available for sale in a particular country, write to womenshealth@hologic.com.